# Cellebrite Initiates Plans to Redomicile in the United States

- Link: https://www.thailand-business-news.com/pr-news/cellebrite-initiates-plans-to-redomicile-in-the-united-states
- Published: 2026-09-14T19:00:00+07:00
- Author: PR Newswire

|   |

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 14, 2026 /PRNewswire/ — Cellebrite
DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and 
Intelligence solutions for the public and private sectors, announced today that 
the Company’s Board of Directors has authorized Cellebrite to pursue a corporate
reorganization, establishing a new United States corporation as the ultimate parent
company, subject to shareholder and regulatory approvals.

Shiv Ramji, Cellebrite’s chief executive officer, said, "Redomiciling is a strategic
evolution of our company structure. We believe redomiciling in the U.S. will better
position us to drive growth across our key customer segments in our largest geographic
market as well as with other large government customers outside of the U.S. Redomiciling
will also increase Cellebrite’s appeal across a broader investor pool through inclusion
in key indices."

Cellebrite anticipates that the redomiciling will be completed by the first half
of 2027, pending successful shareholder and regulatory approvals. Cellebrite plans
to share additional details in the coming months, including those related to a special
general meeting of shareholders, through additional filings with the U.S. Securities
and Exchange Commission.

**Caution Regarding Forward Looking Statements**

This document includes "forward-looking statements" within the meaning of the "safe
harbor" provisions of the United States Private Securities Litigation Reform Act
of 1995. Forward looking statements may be identified by the use of words such as"
forecast," "intend," "seek," "target," "anticipate," "will," "appear," "approximate,""
foresee," "might," "possible," "potential," "believe," "could," "predict," "should,""
could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and"
project" and other similar expressions that predict, project or indicate future 
events or trends or that are not statements of historical matters. Such forward-
looking statements include, but are not limited to, the anticipated timeframe for
completing the redomiciling and the anticipated benefits from redomiciling such 
as it will better position us to drive growth across our key customer segments in
our largest geographic market as well as with other large government customers outside
of the U.S and that it will increase Cellebrite’s appeal across a broader investor
pool through inclusion in key indices. A number of factors could cause actual results
or outcomes to differ materially from those indicated by such forward-looking statements.
These factors include, but are not limited to: Cellebrite’s ability to keep pace
with technological advances and challenges and evolving industry standards with 
respect to software, artificial intelligence, or device access, to adapt to changing
market potential within our markets and to successfully launch new solutions and
add-ons that meet or exceed customer needs; our material dependence on the acceptance
of our solutions by domestic and international law enforcement, public safety, defense
and intelligence agencies; real or perceived errors, failures, defects or bugs in
our solutions; licensing of technology from third parties, including our dependence
on maintaining those licenses or seeking alternative solutions; failure to maintain
the productivity of sales and marketing personnel, including relating to hiring,
integrating and retaining personnel; intense competition in all of our markets, 
including risks associated with pricing pressures from and loss of market share 
to competitors with greater resources than we have and increasing competition as
a result of consolidation in the industry; the misuse of our solutions by our customers
which may achieve suboptimal results or be perceived as incompatible with human 
rights; our ability to properly manage our growth as a business, and execute new
offerings, developments and strategic opportunities, including joint ventures, partnerships
and acquisitions; our dependence on our customers to renew their subscriptions and
purchase additional subscriptions or services from us; conducting a low volume of
our business via e-commerce; the use of artificial intelligence in our digital investigation
platform; the availability of financing sources on reasonable terms or at all; our
reliance on third-party suppliers for certain components, products or services, 
including risks relating to the availability of raw materials or components; challenges
associated with large transactions, including with respect to longer sales cycles,
as well as with developing, offering, implementing, and maintaining new solutions;
risk of security vulnerabilities or defects, including cyber-attacks, information
technology system breaches, failures or disruptions which are critical to our operations
and maintaining the trust and confidence of our customers; risks associated with
political, geo-political and reputational factors related to our business or operations,
including Cellebrite operations in Israel and/or negative publicity, including with
respect to the nature of our solutions; risks associated with our ability to obtain
CFIUS approval for the acquisition of Corellium and with our ongoing compliance 
with national security agreements entered into with the U.S. government; risks that
our intellectual property rights may not be adequate to protect our business or 
assets or that others may make claims on our intellectual property, claim infringement
on their intellectual property rights, or claim a violation of their license rights,
including relative to free or open-source-software components we may use risks relating
to the regulatory constraints to which we are subject, including Israeli export 
laws, our compliance with such laws and related export licenses issued from the 
government of Israel; risks associated with different corporate governance requirements
applicable to Israeli companies and risks associated with being a foreign private
issuer; risks associated with our significant international operations, including
due to our Israeli operations, fluctuations in foreign exchange rates, rising global
inflation, and exposure to regions subject to political or economic instability,
including the State of Israel; uncertainties regarding the impact of changes in 
macroeconomic and/or global conditions, including as a result of slowdowns, recessions,
economic instability, political unrest, or outbreaks of disease, as well as the 
resulting impact on information technology spending and government budgets, on our
business and other factors, risks and uncertainties set forth in the section titled"
Risk Factors" in Cellebrite’s annual report on Form 20-F filed with the U.S. Securities
and Exchange Commission ("SEC") on March 3, 2026, and in other documents filed by
Cellebrite with the SEC, which are available free of charge at [www.sec.gov](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4772965-1&h=1545982054&u=http%3A%2F%2Fwww.sec.gov%2F&a=www.sec.gov).
You are cautioned not to place undue reliance upon any forward-looking statements,
which speak only as of the date made, in this communication or elsewhere. Cellebrite
undertakes no obligation to update its forward-looking statements, whether as a 
result of new information, future developments or otherwise, should circumstances
change, except as otherwise required by securities and other applicable laws.

**About Cellebrite **

Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses
as a global leader in digital investigative and intelligence solutions. More than
7,000 global law enforcement agencies, defense and intelligence organizations and
enterprises trust Cellebrite’s AI-powered software portfolio to make forensically
sound digital data more accessible and actionable. Cellebrite technology allows 
customers to accelerate nearly 3 million legally sanctioned investigations annually,
enhance sovereign security, elevate operational efficacy and efficiency and enable
advanced mobile research and application security. Available via cloud, on-premises
and hybrid deployments, Cellebrite’s technology enables its customers around the
globe to advance their missions, elevate public safety and safeguard data privacy.
To learn more, visit us at **[www.cellebrite.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4772965-1&h=2886945939&u=https%3A%2F%2Fwww.cellebrite.com%2F&a=www.cellebrite.com)**
and **[https://investors.cellebrite.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4772965-1&h=2214225196&u=https%3A%2F%2Finvestors.cellebrite.com%2F&a=https%3A%2F%2Finvestors.cellebrite.com)**
and find us on social media @Cellebrite.

**Contacts:**

**Investors Relations**
Andrew KramerVice President, Investor Relations & Treasury
[investors@cellebrite.com](https://www.thailand-business-news.com/pr-news/investors@cellebrite.com)
+1 973.206.7760

**MediaJackie Labrecque
Director, PR and Executive Communications[jackie.labrecque@cellebrite.com](https://www.thailand-business-news.com/pr-news/jackie.labrecque@cellebrite.com)
+1 771.241.7010

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Cellebrite Initiates Plans to Redomicile in the United States ](http://www.prnasia.com/story/archive/5046640_AE46640_0?rand=184833)